Published in Telemedicine Week, July 4th, 2006
"The first aim of the study was to determine whether 99mTc-HYNIC-annexin V, a marker of cellular stress and apoptosis, can detect ischemic injury in patients with acute stroke. Secondly, we wished to test radiolabeled annexin's ability to monitor therapy in a rodent model of focal ischemic injury. SPECT imaging of patients was performed between one and two hours after intravenous injection of 30 mCi (1,110 MBq) of tracer," investigators in the United States report.
"Eight MFL4 (anti-FasL) antibody-treated (400 mcg i.p. days 0 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.